Paper

Phase 1 clinical trial of S64315, an intravenous MCL1 inhibitor, in patients with myeloid malignancies

Leukemia & lymphoma/Leukemia and lymphoma · 2026 · Norbert Vey, Olga Salamero, Ashish Bajel et al.